Additionally, western blot analysis of tumor tissues demonstrated that compound 3 plus cDDP resulted in greater inhibition of P-EGFR, P-AKT and P-Erk1/2 compared with the individual drugs and control groups (Fig. 7f). The gene discussed is MAPK3; the disease is neoplasm.